000303954 001__ 303954
000303954 005__ 20250821114622.0
000303954 0247_ $$2doi$$a10.1093/jncimonographs/lgaf007
000303954 0247_ $$2pmid$$apmid:40828157
000303954 0247_ $$2ISSN$$a1052-6773
000303954 0247_ $$2ISSN$$a1745-6614
000303954 037__ $$aDKFZ-2025-01729
000303954 041__ $$aEnglish
000303954 082__ $$a610
000303954 1001_ $$00000-0003-2400-2935$$aSchmitz, Kathryn H$$b0
000303954 245__ $$aExercise oncology comes of age.
000303954 260__ $$aOxford$$bOxford Univ. Press$$c2025
000303954 3367_ $$2DRIVER$$aarticle
000303954 3367_ $$2DataCite$$aOutput Types/Journal article
000303954 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755758240_3177
000303954 3367_ $$2BibTeX$$aARTICLE
000303954 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303954 3367_ $$00$$2EndNote$$aJournal Article
000303954 520__ $$aExercise oncology is coming of age, with more than 30 000 peer-reviewed citations in the scientific literature and multiple guidelines published by major medical institutions based on strong evidence from randomized controlled trials. There is enthusiasm around the formation of a new international organization that will form a nexus for exercise oncology researchers, clinicians, and practitioners. The contents of this monograph document the progression of exercise oncology research and practice, laying the groundwork for the formation of the International Society of Exercise Oncology. The society will aim to be an organizing body to shepherd the field toward the goal of using exercise as standard of care in the setting of oncology in collaboration with existing medical organizations so that every patient can benefit.
000303954 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000303954 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303954 7001_ $$0P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aWiskemann, Joachim$$b1$$udkfz
000303954 7001_ $$aMay, Anne M$$b2
000303954 773__ $$0PERI:(DE-600)2044141-1$$a10.1093/jncimonographs/lgaf007$$gVol. 2025, no. 71, p. 301 - 303$$n71$$p301 - 303$$tJournal of the National Cancer Institute / Monographs$$v2025$$x1052-6773$$y2025
000303954 909CO $$ooai:inrepo02.dkfz.de:303954$$pVDB
000303954 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000303954 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000303954 9141_ $$y2025
000303954 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-12$$wger
000303954 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-12
000303954 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-12
000303954 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-12
000303954 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-12
000303954 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-12
000303954 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lAngewandte Tumor-Immunität$$x0
000303954 980__ $$ajournal
000303954 980__ $$aVDB
000303954 980__ $$aI:(DE-He78)D120-20160331
000303954 980__ $$aUNRESTRICTED